BioWorld-International-2002-01-23

No Abstract

No Abstract

No Abstract

No Abstract

No Abstract

No Abstract

No Abstract

PARIS Immuno-Designed Molecules SA, a Paris-based company specialized in the development of cellular immunotherapies for cancer, signed a co-development agreement with the French pharmaceutical company Sanofi-Synthélabo SA covering the whole range of IDM’s “cell drugs” for cancer.

No Abstract

No Abstract